Commentary from the Editors of the Continuing Education Section

Affiliations

Comment

Heiko Schöder et al. J Nucl Med. 2018 Aug.

. 2018 Aug;59(8):1183.

No abstract available

Comment on

Controversial Issues in Thyroid Cancer Management.
Tuttle RM. Tuttle RM. J Nucl Med. 2018 Aug;59(8):1187-1194. doi: 10.2967/jnumed.117.192559. Epub 2018 Apr 13. J Nucl Med. 2018. PMID: 29653980 Free PMC article. Review.
A Matter of Controversy: Is Radioiodine Therapy Favorable in Differentiated Thyroid Carcinoma?
Schmidt M, Görges R, Drzezga A, Dietlein M. Schmidt M, et al. J Nucl Med. 2018 Aug;59(8):1195-1201. doi: 10.2967/jnumed.117.191338. Epub 2018 May 10. J Nucl Med. 2018. PMID: 29748234 Review.
Controversies on the Use of Radioiodine in Thyroid Cancer: We Need More and Better Data.
Pryma DA. Pryma DA. J Nucl Med. 2018 Aug;59(8):1184-1186. doi: 10.2967/jnumed.118.214197. Epub 2018 Jun 22. J Nucl Med. 2018. PMID: 29934408 Review. No abstract available.